Proactive Investors - Run By Investors For Investors

Canntab Therapeutics wins Health Canada hemp cultivation license

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCMKTS:CTABF) CFO Richard Goldstein tells Proactive Investors the Canadian company has achieved a major milestone by receiving a cultivation license from Health Canada.

The license allows Canntab to cultivate industrial hemp, said Goldstein adding it intends to use the license to secure hemp biomass that it will use to extract CBD to manufacture cannabis hard pills.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full PILL profile View Profile

Canntab Therapeutics Ltd Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use